Metformin Protects Ovarian Reserve in Mice from Chemotherapy Damage
Author Information
Author(s): Zatalian Negin, Dalman Azam, Afsharian Parvaneh, Hezavehei Maryam, Gourabi Hamid
Primary Institution: University of Science and Culture and Royan Institute
Hypothesis
Does metformin mitigate the ovarian damage caused by cyclophosphamide in prepubertal mice?
Conclusion
Metformin can help preserve ovarian function in mice treated with cyclophosphamide by regulating key signaling pathways.
Supporting Evidence
- Metformin increased AMH levels in treated mice.
- Metformin reduced the activation of primordial follicles.
- Metformin improved ovarian volume compared to cyclophosphamide treatment alone.
- Metformin modulated the expression of genes in the PI3K/Akt/mTOR pathway.
Takeaway
Metformin is like a superhero for young mice's ovaries, helping them stay healthy even when they get a medicine that usually makes them sick.
Methodology
The study involved 24 prepubertal female mice divided into four groups, with treatments including metformin and cyclophosphamide, followed by analysis of ovarian health.
Limitations
The study was conducted on mice, which may not fully replicate human responses to chemotherapy and metformin.
Participant Demographics
14-day-old NMRI female mice
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website